MDRM (Modern Mobility Aids) Beta: -0.1458 (As of Jun. 24, 2026)


What is Modern Mobility Aids Beta?

Modern Mobility Aids MDRM Beta is -0.1458 as of Jun. 24, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Modern Mobility Aids's Beta is -0.1458.


Modern Mobility Aids  (OTCPK:MDRM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Modern Mobility Aids Beta Related Terms


Modern Mobility Aids Beta Historical Data

* Premium members only.

The historical data trend for Modern Mobility Aids's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Mobility Aids Beta Chart

Modern Mobility Aids Annual Data
Trend Jun10 Jun11 Jun12 Jun13 Jun14
Beta
0.00 0.00 0.00 -0.63 5.24

Modern Mobility Aids Quarterly Data
Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.32 5.24 8.75 12.00 11.65

MDRM vs MGPC, POYN, IVFZF: Beta Comparison

For the Health Information Services subindustry, Modern Mobility Aids's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Mobility Aids Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Modern Mobility Aids's Beta distribution charts can be found below:

* The bar in red indicates where Modern Mobility Aids's Beta falls into.



Modern Mobility Aids Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1458 mean?
Modern Mobility Aids (MDRM) has a Beta of -0.1458 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Modern Mobility Aids and its competitors.
Is Modern Mobility Aids' Beta too high?
Modern Mobility Aids' current Beta is -0.1458.
How does Modern Mobility Aids' Beta compare to MGPC and POYN?
Modern Mobility Aids' Beta of -0.1458 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Modern Mobility Aids and its competitors. Modern Mobility Aids's current Beta is -0.1458. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Mobility Aids stock overvalued right now?
Modern Mobility Aids (MDRM) has a current Beta of -0.1458. The current Beta is -0.1458. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Modern Mobility Aids (MDRM), the current Beta is -0.1458 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Mobility Aids Business Description

Address 1968 South Coast Highway, Suite1094, Laguna Beach, CA, USA, 92651
Modern Mobility Aids Inc is currently focusing on Digital Health, Telehealth, Virtual Care, Cardiac Monitoring, Mental Health, Tele-Monitoring, and other emerging opportunities in the rapidly changing healthcare environment, with a special emphasis on the Canadian, Latin American, and US markets. The company aims to build a common/shared platform through which it can provide Virtual Health Care services and home medical monitoring.